StocksMedium•3 November 2026•
1 min read
Pfizer Stock Edges Lower Despite Q3 Earnings Beat and Guidance Hike
Key Facts
1Pfizer reported adjusted earnings of 87 cents per share, exceeding analyst expectations of 74 cents.
2The company's Q3 sales reached $16.58 billion, beating estimates of $15.85 billion.
3The pharmaceutical company raised its forward guidance and appointed a new Chief Financial Officer.
Pfizer reported adjusted earnings of 87 cents per share for the third quarter, exceeding analyst expectations of 74 cents. Investor's Business Daily reported that the company's sales reached $16.58 billion, beating estimates of $15.85 billion. Following the strong operational performance, the pharmaceutical company raised its forward guidance and announced the appointment of a new Chief Financial Officer.
PFE closed at $30.67 on November 2, 2026, with the stock reaching a day high of $31.04 and a low of $30.20. These financial results coincide with broader economic data, including the ISM Manufacturing PMI which reached 55.5 on November 2, 2026, performing above previous forecasts.